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Abstract
The therapeutic implications of bicuspid aortic valve associations have come under 
scrutiny in the transcatheter aortic valve implantation era. We evaluate the spectrum 
of mitral valve disease in patients with bicuspid aortic valves to determine the need for 
closer echocardiographic scrutiny/follow-up of the mitral valve. A retrospective analysis of 
echocardiograms done at a referral hospital over five years was conducted in patients with 
bicuspid aortic valves with special attention to congenital abnormalities of the mitral valve. 
One hundred and forty patients with a bicuspid aortic valve were included. A congenital 
mitral valve abnormality was present in eight (5.7%, P = 0.01) with a parachute mitral valve 
in four (2.8%), an accessory mitral valve leaflet in one (0.7%), mitral valve prolapse in one, 
a cleft in one and the novel finding of a trileaflet mitral valve in one. Minor abnormalities 
included an elongated anterior mitral valve leaflet (P < 0.001), the increased incidence of 
physiological mitral regurgitation (P < 0.001), abnormal papillary muscles (P = 0.002) and an 
additional chord or tendon in the left ventricle cavity (P = 0.007). Mitral valve abnormalities 
occur more commonly in patients with bicuspid aortic valves than matched healthy 
individuals. The study confirms that abnormalities in these patients extend beyond the 
aorta. These abnormalities did not have a significant functional effect.
Introduction
Bicuspid aortic valves (BAVs) are a common congenital 
cardiac abnormality occurring in 0.5–1.4% of the 
general population (1). The underlying pathophysiology 
remains unclear with abnormalities in cell migration, 
signalling pathways and genetic susceptibility 
postulated (2). While BAVs can occur in isolation, its 
presence should prompt a full evaluation for associated 
cardiovascular and congenital defects, including, but 
not restricted to an aortopathy with or without aortic 
root dilatation (3), aorta coarctation (4) and the rare, 
but interesting, Shone complex (5). The therapeutic 
implications of BAV associations have come under 
renewed scrutiny in the era of transcatheter aortic valve 
implantation.
The association between mitral valve dysfunction 
and BAVs has not been well defined yet. However, several 
studies have shown what appears to be more than a 
coincidental link between bicuspid aortic valve and mitral 
valve prolapse (6, 7, 8) with an incidence as high as 5% 
reported in this setting by Schaeffer and coworkers (9). 
An association with rare congenital abnormalities of the 
mitral valve has been suggested, including a case report 
of a double orifice mitral valve in the setting of a bicuspid 
aortic valve (10). Minor structural abnormalities of the 
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mitral valve in the setting of BAVs have also been reported 
with one small study showing an association with an 
abnormal anterior mitral valve leaflet (11). The association 
of BAV and Shone complex, a rare disease involving 
obstruction of the left ventricular outflow (valvular/
subvalvular stenosis or coarctation) and inflow (parachute 
mitral valve or supravalvular mitral membrane) (5), is an 
uncommon yet interesting one as it serves to illustrate 
the range of congenital abnormalities, including those 
of the mitral valve, that can coexist in patients with BAV. 
The complex is also often present in a forme fruste, and 
based on first principles, it is possible that this syndrome 
is underreported in its milder forms.
Left ventricular outflow tract or aorta abnormalities 
that are commonly associated with BAVs include 
coarctation of the aorta (22–60%) (4), supravalvular 
stenosis (37%) (12) and subvalvular stenosis (23%) (13), 
sinus of valsalva aneurysm, ascending aortic aneurysm 
and aortic dissection (3). Other congenital abnormalities 
occurring in the setting of BAVs include ventricular septal 
defect, patent ductus arteriosus and atrial septal defect 
(2) as well as coronary artery abnormalities including 
reversal of coronary dominance, a short left main stem 
(<5 mm) and single coronary arteries (14, 15). The 
heterogeneity in the associated lesions could suggest a 
more global disorder of cardiac development as a basis for 
the disorder, while the association with left ventricular 
outflow tract obstruction not only suggests a possible 
shared pathophysiology but also fulfils two of the four 
components of the Shone complex in a large proportion 
of patients. Given these findings, it is possible that the 
incidence of congenital abnormalities of the mitral valve 
in the setting of BAVs is higher than originally thought. 
We therefore postulated that the morphology of the mitral 
valve might be abnormal in these patients even in the 
absence of a clearly identifiable congenital abnormality 
or functional impairment. This would warrant careful 
scrutiny for detection and follow-up of the mitral valve 
in these patients even if the bicuspid aortic valve was 
surgically corrected or replaced and could have treatment 
implications in the current transcatheter aortic valve 
implantation era.
Methods
A retrospective echocardiographic analysis was conducted 
at Tygerberg hospital, a 1300-bed academic hospital in 
South Africa serving a population of 3.6 million people of 
predominantly mixed racial descent. All echocardiograms 
done at this institution are saved on a central EchoPAC 
database with the complete echocardiogram video 
clips available for review. In selected cases with clear 
pathology, 3D echocardiograms were available for review. 
Information on the age and gender of the patients were 
also obtained from this database.
All reports of echocardiograms done between January 
2011 and December 2015 were screened for evidence 
of confirmed or suspected bicuspid aortic valve disease 
or bicuspid aortic valve disease spectrum (unicuspid 
and quadricuspid valves). These echocardiograms 
were then reviewed by the principal investigator to 
confirm the presence of bicuspid spectrum aortic valve 
disease. Uncertain cases were reviewed by the principle 
investigator and co-investigator (PG Herbst), and a joint 
decision was made. All patients with bicuspid spectrum 
aortic valve disease were included regardless of whether 
an intervention was done on the aortic valve, provided 
that there was adequate documentation to support the 
diagnosis of the congenital abnormality. Cases where an 
intervention on the mitral valve had already been done 
and no echocardiogram prior to the intervention was 
available for review were excluded. Studies were then 
evaluated with special attention to the presence of any 
congenital abnormalities of the mitral valve.
First, BAVs were classified according to whether or 
not a raphe was present. If a raphe was present, they 
were further subdivided into type 1 (right-left coronary 
cusp fusion), type 2 (right-noncoronary cusp fusion) and 
type 3 (left-noncoronary cusp fusion) (16). Functional 
evaluation of the aortic valve using standard European 
Association of Echocardiography guidelines (17, 18) was 
then performed.
Cases were then evaluated for obvious congenital 
abnormalities of the mitral valve. Abnormalities were 
classified, according to the part of the mitral valve 
complex involved, into leaflet abnormalities (mitral valve 
prolapse, cleft anterior mitral valve leaflet, mitral ring 
and Ebstein’s malformation), abnormalities of the tensor 
apparatus (arcade/hammock mitral valve, straddling 
mitral valve) and abnormalities of the papillary muscles 
(parachute mitral valve). Subsequently, studies were 
evaluated for more subtle morphological abnormalities, 
which included measuring the mitral valve annulus 
diameter, the anterior mitral valve leaflet length and 
papillary muscle number and position. Mitral valve 
annulus diameter was measured in the parasternal long 
axis just before mitral valve opening at end-systole. In 
cases where the parasternal long axis was unavailable or of 
poor image quality, the apical 3-chamber view was used. 
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The anterior mitral valve leaflet length was measured 
in the same view from the base of the anterior mitral 
valve leaflet where it joins the aortic leaflet hinge point 
(annulus) to the tip of the anterior mitral valve leaflet in 
a frame with the full length of the leaflet visible. Care was 
taken not to measure chordal structures. The assessment of 
the papillary muscles included noting the number as well 
as the shape and size of the papillary muscles. Papillary 
muscles are usually defined not only as muscles located 
in the ventricles but also as attaching to the cusps of the 
atrioventricular valves via the chordae tendineae. For the 
purpose of this study, we included all additional muscles 
that had the appearance of a papillary muscles regardless 
of whether chordal attachments were demonstrated. 
The papillary muscle position was then measured on 
the parasternal short axis view according to the method 
defined by Stanley and coworkers (19). A fixed reference 
point (0°) was defined at the medial junction of the right 
ventricular free wall with the posteroinferior ventricular 
septum. A point was then placed into the centre of the 
left ventricle, and the position of both papillary muscles 
in degrees of arc was then measured around the point 
representing the centre of the left ventricle from 0° to the 
middle of the base of the anterolateral and posteromedial 
papillary muscles (Fig.  1). The presence of anomalous 
chordae or false tendons within the left ventricle as well 
as the insertion points of these structures were noted if 
present. This was followed by a functional evaluation 
of mitral valve using standard European Association of 
Echocardiography guidelines (20).
The presence of subvalvular/supravalvular obstruction 
was noted as well as the presence of an aortopathy which 
was classified into three types based on the pattern of 
aortic involvement described by Verma and coworkers 
(21). Aortic diameters were measured on 2D imaging 
(inner edge to inner edge) with all measurements taken 
at end-diastole.
One hundred and forty-six controls were obtained 
from both normal volunteers and patients not known 
with any cardiac disease requiring pre-chemotherapy 
screening echocardiograms.
Patients with complex congenital heart disease 
causing marked distortion of the normal cardiac anatomy 
were not matched, but were included for other parameters. 
Children younger than 16 years were also not matched, 
and their linear measurements were not included in the 
overall assessment given the marked difference in the age-
related normal range.
This study complies with the Declaration of Helsinki. 
Ethics approval was obtained from the local ethics 
committee who waived informed consent given the 
retrospective nature of this study.
Statistical analysis
IBM SPSS version 22 was used to analyse the data. A 
P value <0.05 was considered statistically significant. 
All morphological data are presented as mean ± 1 s.d. 
Pearson’s chi-square tests, Student’s t-test as well as 
ANOVA methods were employed to explore and compare 
differences in variables between the groups, allowing for 
multiple testing corrections. Linear regression analyses 
were also performed to explore the relations between 
measurements as well as to identify group effects.
Results
Baseline characteristics
A total of 23,784 echocardiography reports were screened, 
and 210 patients were identified of which 140 patients 
Figure 1
Diagram illustrating how positions of papillary muscle were obtained in 
degrees of arc. A parasternal short axis view at the level of the papillary 
muscles was used. A fixed reference point (0°) was defined at the medial 
junction of the right ventricular free wall with the inferior ventricular 
septum. A point was then placed into the centre of the left ventricle, and 
the positions of both papillary muscles in degrees of arc were then 
measured around the point representing the centre of the left ventricle 
from 0° to the middle of the base of the anterolateral and posteromedial 
papillary muscles. Illustrated in this diagram is the normal papillary 
muscle position as evaluated in our study. The papillary muscles in 
patients with BAV were displaced with approximately 9°. AL PM, 
anterolateral papillary muscle; IVS, intraventricular septum; LV, left 
ventricle; PM PM, posteromedial papillary muscle; RV, right ventricle.
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fulfilled criteria for inclusion (Fig. 2). The median age was 
44 years (range 1–90), and 60% were male.
Aortic valve morphology and function
A raphe was present in 82 patients (59%), which included 
42 patients with type 1, 31 patients with type 2 and 9 
patients with type 3 bicuspid aortic valve morphology. 
Fifty patients (36%) had BAVs without raphes. In one 
patient with previous surgery to his aortic valve, the type 
of bicuspid aortic valve was unknown. The remaining 7 
patients (5%) had quadricuspid aortic valves.
Aortic stenosis was present in 82 patients (58.6%) 
with severe aortic stenosis present in 40 patients (48.7%) 
with 5 (6%) of these patients having low-gradient severe 
aortic stenosis. Aortic regurgitation was present in 103 
patients (73.6%), but it was mild or trivial in 54 patients 
(52.4%) and severe in only 12 patients (11.6%).
Mitral valve morphology and function
A clear congenital abnormality of the mitral valve was 
present in 8 patients (5.7%; Table 1). This was statistically 
significant compared to the control group (P = 0.01; 
LR 9.4). The most common abnormality was a parachute 
mitral valve, which was present in four patients (2.8%). 
Of these patients, one had the complete Shone complex, 
two had three of the four components, and the remaining 
patient had only two components. One patient (0.7%) 
had an accessory mitral valve leaflet, one patient had 
mitral valve prolapse, one patient had a cleft in the 
anterior mitral valve leaflet, and one patient a novel 
echocardiographic finding of a trileaflet mitral valve 
with three commissures and three associated papillary 
muscles supplying chords to the mitral valve (Fig.  3). 
The entire bicuspid aortic valve spectrum found in our 
cohort was represented in the group with mitral valve 
disease. There was no clear pattern or association with 
the type of bicuspid aortic valve and the presence of 
mitral valve disease.
Mitral regurgitation was present in 75 patients 
(53.6%). It was mild or trivial in 68 patients (90.7%), 
moderate in six patients (8%) and severe in one patient 
(1.3%). In the majority of cases, the mitral regurgitation 
was considered to be physiological, either often due to 
a prominent interscallop separation in the posterior 
mitral valve leaflet or due to tethering of an otherwise 
normal valve. However, mitral regurgitation from any 
cause was statistically significantly associated with the 
presence of a bicuspid aortic valve (P < 0.001; LR 28.9), 
and this difference persisted if mitral regurgitation due to 
congenital mitral valve disease (P < 0.001) or congenital 
mitral valve disease and/or tethering was excluded 
(P = 0.02). Mitral stenosis was present in only one patient 
Figure 2
Flow diagram showing inclusion and exclusion 
criteria.
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with a parachute mitral valve and a mitral valve area 
of 1.6 cm2.
The anterior mitral valve leaflet was significantly 
longer in all of the patients (P = <0.001) even if corrected 
for left ventricular end diastolic diameter (Table 2).
Abnormalities of the papillary muscles were 
frequently present (P = 0.002) with the most common 
abnormality, an additional papillary muscle (P < 0.001) 
typically positioned more anteriorly in degrees of arc 
than the anterolateral papillary muscle. More than 1 
additional papillary muscle was frequently present with 
up to 7 papillary muscles seen in one patient. A papillary 
muscle complex or single papillary muscle was seen in 
the patients with parachute mitral valve. Both papillary 
muscles were also found to be positioned more anteriorly 
in degrees of arc in patients with BAVs (P < 0.001).
A false tendon or chord was seen in the left ventricle 
in 27 patients (19.3%). The majority of these were in 
the mid-ventricle or apex, but in four patients, a thick, 
prominent chord/tendon extended to the base of the 
anterior septum giving a very abnormal appearance, but 
no functional effect.
Aortopathy, subvalvular and supravalvular obstruction
An associated aortopathy was present in 49 patients (35%) 
with type 1 aortopathy present in 29 patients, type 2 in 14 
patients and type 3 in 6 patients. Subvalvular obstruction 
was present in 8 (5.7%). This was due to a subvalvular 
ridge in four patients, a subvalvular membrane in three 
patients with one patient having an accessory mitral valve 
leaflet causing left ventricular outflow tract obstruction. 
Supravalular obstruction was present in 11 patients (7.9%) 
with 10 patients having aorta coarctation and 1 patient an 
interrupted aortic arch.
Discussion
A clear congenital abnormality of the mitral valve was 
statistically significantly (P = 0.01) associated with a 
bicuspid aortic valve when compared to the control group. 
Mitral valve abnormalities in this cohort were equally 
divided between leaflet abnormalities and abnormalities 
of the papillary muscles rather than a single associated 
lesion. This suggests a spectrum of mitral valve disease in 
the setting of a bicuspid aortic valve rather than a single 
associated lesion.
Interestingly, congenital abnormalities of the mitral 
valve leaflets predominantly involved the anterior leaflet Ta
b
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with prolapse of the A2 segment, an accessory mitral 
valve leaflet attached to the anterior mitral valve leaflet 
as well as a cleft in the anterior mitral valve leaflet. More 
subtle abnormalities of the anterior mitral valve leaflet 
were also found, which could suggest that a structurally 
abnormal anterior mitral valve leaflet may be present 
in patients with BAVs and play an important role in 
the spectrum of congenital mitral valve disease in these 
patients. The anterior mitral valve leaflet in our bicuspid 
aortic valve cohort measured statistically significantly 
longer when compared with the control group (P < 0.001). 
This was in keeping with our visual impression as well as 
supporting the findings of a previous smaller study (10). 
In our cohort, none of the patients had systolic anterior 
motion of this abnormally long anterior mitral valve 
leaflet, and therefore no functional implications of this 
abnormality were noted. However, this could become 
clinically relevant in the post-operative setting where 
systolic anterior motion of the mitral valve is more likely 
to occur. The incidence of mitral valve prolapse in our 
cohort was much lower than the 5% incidence reported by 
Schaeffer and coworkers (9). Since both studies were done 
retrospectively with reasonably similar cohort sizes, this 
finding was unexpected. It may be an illustration of the 
known marked variation in the phenotypic presentation 
of bicuspid aortic valve disease, but subtle bias in the way 
retrospective cohorts are constructed cannot be excluded.
The most common abnormality congenital 
abnormality of the mitral valve in out cohort was a 
parachute mitral valve. More subtle abnormalities of the 
papillary muscles were also frequently noted. Additional 
papillary muscles were found in 37 of the matched patients 
with many patients having multiple additional papillary 
muscles. These papillary muscles were typically anteriorly 
positioned, just above the anterolateral papillary muscles. 
Table 2 Echocardiographic parameters for matched patients 
with BAV compared with age and gender matched controls.
 Controls (N = 146) BAV (N = 125) P value
Ao annulus (cm) 2.1 ± 0.21 2.2 ± 0.34 0.065
Ao sinus (cm) 2.9 ± 0.37 3.1 ± 0.67 <0.001
Ao STJ (cm) 2.4 ± 0.34 2.7 ± 0.7 <0.001
Ao Asc (cm) 2.4 ± 0.38 2.9 ± 0.84 <0.001
MV annulus (cm) 2.8 ± 0.29 2.9 ± 0.48 0.07
AMVL length (cm) 2.6 ± 0.35 3.0 ± 0.46 <0.001
PM position (PM) (°) 
(N = 133)
309 ± 19 300.8 ± 19.7 0.001
PM position (AL) (°) 189 ± 19.7 178.7 ± 22.7 <0.001
Abnormal PM 
(N = 134)
21 37 0.002
Additional PM 21 35 0.004
False tendon/chord 14 27 0.007
AMVL, anterior mitral valve leaflet; Ao, aorta; BAV, bicuspid aortic valve; 
MV, mitral valve; PM, papillary muscle; STJ, sinotubular junction.
Figure 3
Congenital mitral valve abnormalities. Panel A and B: parasternal short axis views illustrating the novel finding of a trileaflet mitral valve with three 
papillary muscles (arrows) and three commissures (arrows) clearly visible. Parasternal long axis view (panel C) and parasternal short axis view (panel D) 
showing a parachute mitral valve. Note the intrinsic stenosis of a parachute mitral valve illustrated in the short axis, which was taken at the leaflet tips. 
Chords in this patient extended to a papillary muscle complex. Panel E: parasternal long axis view that shows a false tendon/chord extending from the 
posterior wall to the base of the anterior septum. While this created an abnormal appearance, it did not have a functional effect. Panel F: parasternal 
short axis view showing multiple additional papillary muscles (arrows).
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These papillary muscles had a typical appearance, but 
chords to the mitral valve leaflets were not seen except in 
the patient with a trileaflet mitral valve. When measured 
in degrees of arc, both papillary muscles were positioned 
more anteriorly than expected. Even though the absolute 
difference was small, this again suggests that abnormalities 
of the papillary muscles extend beyond just a parachute 
mitral valve.
While abnormalities of the tensor apparatus of the 
mitral valve were not found in our cohort, an interesting 
finding was the frequent observation of a chord or 
tendon extending across the left ventricular cavity 
(P = 0.009). These were typically thin structures with 
no functional effect, but in four patients, these chords 
extended to the base of the anterior septum creating a 
very abnormal appearance.
Functionally, mitral regurgitation was a common 
finding present in more than half of patients. Even 
if congenital mitral valve disease or tethering due to 
ventricular dilatation or impaired systolic function 
related to the bicuspid aortic valve was excluded, mitral 
regurgitation was still a much more frequent finding 
in the study population than in the controls (P = 0.02). 
Mitral stenosis was an uncommon finding only present 
in one of the patients and was due to a parachute mitral 
valve. None of the congenital abnormalities had a 
functionally significant effect with only one patient with 
a congenital mitral valve abnormality having more than 
mild mitral regurgitation and no patients having severe 
mitral regurgitation.
The prevalence of bicuspid aortic valve in screening 
studies among the general population is reported as 
0.5–1.4%, while the frequency of BAVs in our screened 
cohort was 0.6%. Of course this is a study using a very 
different cohort of patients that have already preselected 
themselves for an echocardiogram, and therefore this 
figure is not necessarily generalizable to the prevalence in 
our population. Patients at our institution tend to present 
late in the disease course when it might not be possible 
to accurately differentiate a trileaflet aortic valve from a 
bicuspid aortic valve if significant calcification is already 
present. It is therefore possible that the true incidence 
in our population of predominantly mixed race could 
be substantially higher. Interestingly, a screening study 
currently underway at our institution to detect subclinical 
rheumatic heart disease did not record a single bicuspid 
aortic valve in the more than 2000 participants already 
screened, an observation which is as yet unexplained.
The bicuspid aortic valve morphology in our 
population differed from what is commonly reported. 
Type 1 bicuspid morphology was present in 30% of our 
cohort which, although still the most common type, 
is much less than the approximately 60% reported in 
other cohorts. Less common types like type 2 bicuspid 
morphology (22.1%) and quadricuspid valves (5%) 
occurred with a higher than expected frequency.
An aortopathy was present in 35% of cases, which 
is lower than the expected incidence of around 50% 
reported in other studies (21). This may reflect the fact 
that cases were selected for the presence of BAV rather 
than aortic dilatation primarily. The differences in the size 
of the aortic valve, aortic root and ascending aorta, while 
statistically significant, were also relatively modest given 
the mean age of 44 years in the cohort.
The main limitation of this study is the retrospective 
nature, which might impact on both the number of 
patients included and the accuracy and repeatability 
of the measurements obtained. However, images were 
re-analysed carefully, and multiple studies on the same 
patient were often available for analysis providing 
multiple images to ensure accurate measurements. 3D 
Echocardiography is not performed routinely in all cases 
in our practice, and 3D images were therefore not available 
for inclusion in the retrospective analysis for the majority 
of cases. Although 3D imaging adds useful information to 
the assessment of the mitral valve in selected pathologies 
such as for more complex cases of MVP, we felt that 2D 
imaging answered the specific questions asked in this 
study adequately.
Conclusion
Mitral valve abnormalities occurs more commonly in 
patients with BAVs with a wide spectrum of disease 
ranging from subtle functional changes with an 
increased incidence of physiological mitral regurgitation, 
morphological abnormalities including an increased 
anterior mitral valve leaflet length or additional papillary 
muscles to clear congenital abnormalities including 
parachute mitral valve. While supporting the hypothesis 
that abnormalities in these patients extends beyond 
the aorta, none of these abnormalities had a significant 
functional effect.
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